Sanofi-Aventis Purchases $42.4 Million Worth of Regeneron Pharmaceuticals Inc (REGN)’s Stock

On Jan. 29th, Sanofi-Aventis, a European pharmaceutical group and Large Shareholder at Regeneron Pharmaceuticals Inc (NASDAQ:REGN), filed a Form 4 report at the U.S. Securities and Exchange Commission, declaring several purchases of the company’s stock. On. Jan. 27th the insider acquired – through several different transactions – more than 74,000 shares. On the following day, the pharmaceutical group bought stock yet again; this time, more than 83,000 shares. He paid prices ranging from $270.18 to $279.73 per share, inclusive. After the reported transactions –on which Sanofi spent roughly $42.4 million, the shareholder owns 15.97 million shares of the company worth more than $4.5 billion.

Ken Griffin with computers

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is, as its name clearly indicates, a $28 billion market cap integrated biopharmaceutical company that discovers, develops and manufactures medicines for the treatment of serious medical conditions. The company holds a promising product pipeline and a leading monoclonal antibody research and development platform. Trading at 41.8 times its earnings, a 30% discount versus the industry average valuation, while offering industry leading margins and returns –more than triple the industry mean values, this stock looks like a catch. In fact, most analysts consider this company´s stock to be a buy or strong buy case, and expect it to deliver above average annual EPS growth rates over the next five years (31.5% in average).

Sanofi, a healthcare company more than four times bigger than Regeneron Pharmaceuticals Inc (NASDAQ:REGN) in terms of market cap, continues to invest in this pharmaceutical company and many analysts consider that an acquisition could occur somewhere down the road. If this were to happen, other stockholders could result highly benefited.

Besides analysts and Sanofi, there are several hedge funds that also seem to like Regeneron Pharmaceuticals Inc (NASDAQ:REGN). In its last 13F form, Samuel Isaly´s Orbimed Advisors –the largest “hedgie” bull- declared an increase of 46% in its position in the stock. The fund now holds 513,100 shares, valued at approximately $ 1.46 billion. This position comprised 2.86% of Orbimed´s Q3 equity portfolio.

Second in terms of bullish sentiment is Donald Chiboucis‘ Columbus Circle Investors, which also augmented its bets on Regeneron Pharmaceuticals Inc (NASDAQ:REGN) over the last reported quarter. The fund upped its stakes by 6%, and owned more than 451,500 shares at the end of Q3, which accounted for 1% of its total equity holdings.

Finally, third in line is Ken Griffin’s Citadel Investment Group. The fund boosted its involvement in the company by 1488% in its last reported quarter. Griffin’s fund now owns 383,572 shares. Other prominent funds that also incremented their bets on Regeneron Pharmaceuticals Inc (NASDAQ:REGN) are Jim Simons’ Renaissance Technologies and Adage Capital Management.

 

Disclosure: Javier Hasse holds no position in any stocks mentioned

Recommended Reading:

General Electric Company (GE) Continues to Witness Strong Insider Activity

Irving Kahn and a Board Director Bullish About Old Republic International Corporation (ORI)

Michael Novogratz and Insiders Are Bullish About These 4 Stocks

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Top 10 Highest Paying Jobs in the World

Most Expensive Day-Care in New York City

The 10 Cheapest Places to Retire Abroad

Top 10 Most Expensive Luxury Cars in the World – 2014

Killer Small Business Ideas

The 50 Best Personal Finance Blogs

Most Expensive Apartments in New York City

Bloodiest UFC Fights Ever Fought

Most Expensive Rum Brands in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!